Alunbrig One-Month Initiation Pack
What it is used for
ALUNBRIG is indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib. The approval of this medicine is based on objective response rate and duration of response in a non-comparative study.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Tablet, film coated
Oval, white to off-white with debossed “U7” on one side and plain on the other side
The way to take this medicine is: Oral. This medicine is taken by mouth.
Part 2: Tablet, film coated
Oval, white to off-white with debossed “u13” on one side and plain on the other side.
The way to take this medicine is: Oral. This medicine is taken by mouth.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
How to take it
This medicine is a pack that contains more than one part.
Part 1: Tablet, film coated
Oval, white to off-white with debossed “U7” on one side and plain on the other side
The way to take this medicine is: Oral. This medicine is taken by mouth.
Part 2: Tablet, film coated
Oval, white to off-white with debossed “u13” on one side and plain on the other side.
The way to take this medicine is: Oral. This medicine is taken by mouth.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is